SE | AUC (95%CI) | p-value | Sensitivity | Specificity | PPV | NPV | PLR | NLR | Youden’s index | Associated criterion | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
IFG | Total | 0.01 | 0.56 (0.53–0.58) | <0.001 | 0.61 | 0.48 | 0.70 | 0.38 | 1.17 | 0.81 | 0.09 | 22.22 |
Age | ||||||||||||
18–30 years | 0.02 | 0.54 (0.49–0.58) | 0.104 | -- | -- | -- | -- | -- | -- | -- | -- | |
31–45 years | 0.02 | 0.53 (0.49–0.56) | 0.124 | -- | -- | -- | -- | -- | -- | -- | -- | |
Gender | ||||||||||||
Male | 0.02 | 0.57 (0.54–0.60) | <0.001 | 0.49 | 0.64 | 0.73 | 0.38 | 1.36 | 0.80 | 0.13 | 22.23 | |
Female | 0.02 | 0.53 (0.48–0.58) | 0.188 | -- | -- | |||||||
DM | Total | 0.03 | 0.59 (0.53–0.66) | 0.002 | 0.60 | 0.62 | 0.77 | 0.42 | 1.58 | 0.65 | 0.22 | 22.34 |
Age | ||||||||||||
18–30 years | 0.07 | 0.50 (0.37–0.63) | 0.977 | -- | -- | -- | -- | -- | -- | -- | -- | |
31–45 years | 0.04 | 0.58 (0.50–0.65) | 0.024 | 0.64 | 0.56 | 0.78 | 0.39 | 1.45 | 0.64 | 0.20 | 22.53 | |
Gender | ||||||||||||
Male | 0.04 | 0.61 (0.53–0.70) | 0.004 | 0.63 | 0.62 | 0.78 | 0.43 | 1.66 | 0.60 | 0.25 | 22.41 | |
Female | 0.05 | 0.56 (0.46–0.67) | 0.184 | -- | -- | -- | -- | -- | -- | -- | -- |